^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    BRCA2 deletion

    i
    Other names: BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset
    Entrez ID:
    675
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    Apply
    Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes (NCT02286687)
    Phase 2
    M.D. Anderson Cancer Center
    Active, not recruiting
    Last update posted :
    04/05/2024
    Initiation :
    12/22/2014
    Primary completion :
    12/31/2025
    Completion :
    12/31/2025
    BRCA1 • BRCA2 • PTEN • BRCA
    |
    BRCA2 mutation • BRCA1 mutation • BRCA2 deletion • BRCA1 deletion • BRCA mutation • BRCA deletion
    |
    Talzenna (talazoparib)
    Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2 (NCT05482074)
    Phase 2
    Dana-Farber Cancer Institute
    Withdrawn
    Last update posted :
    01/19/2024
    Initiation :
    10/04/2022
    Primary completion :
    05/01/2026
    Completion :
    05/01/2027
    BRCA1 • BRCA2
    |
    BRCA1 mutation • BRCA2 deletion • BRCA1 deletion
    |
    Lynparza (olaparib)